Surge in projects regarding toxicity studies and drug discovery has led to an upsurge in demand for techniques related to high content screening in the pharmaceutical industry. Moreover, growing support from the government is expected to impact the global market growth of content screening positively. According to a recently published report by Research Report Insights (RRI), the global high content screening market is expected to witness a CAGR growth of 6.1% over the projected period, 2017 ... Read more
Surge in projects regarding toxicity studies and drug discovery has led to an upsurge in demand for techniques related to high content screening in the pharmaceutical industry. Moreover, growing support from the government is expected to impact the global market growth of content screening positively. According to a recently published report by Research Report Insights (RRI), the global high content screening market is expected to witness a CAGR growth of 6.1% over the projected period, 2017 ... Read more
The global high-content screening market is expected to reach USD 909.0 Million by 2022 from USD 557.1 Million in 2017, at a CAGR of 10.3%.
Danaher Corporation holds a leading position in the market. The company designs, manufactures, and markets professional, medical, industrial, and commercial products & services. Danaher Corporation primarily focuses on product launches ... Read more
Factors expected to drive the growth of the market are rising need for cost containment in pharmaceutical R&D, growth in funding for cellular research, and technological advancements in HCS solutions during the forecast period. The increasing number of contract research organizations providing HCS outsourcing services and application of HCS in personalized medicine offer significant growth opportunities in the HCS market. The rising adoption of label-free technologies and growing focus ... Read more
In this report, the market is segmented based on product, application, end user, and region. This report also discusses the key market drivers, restraints, opportunities, and challenges for this market and its submarkets.
The overall high content screening market is expected to grow from USD 506.7 million in 2016 to USD 909.0 million by 2022, at a CAGR of 10.3% from 2017 ... Read more
The global high-content screening (HCS) market is consolidated in nature with the top five players commanding a major share of the market. GE Healthcare (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Becton, Dickinson and Company (U.S.) lead the global market. Some of the other leading players in this market include BioTek Instruments Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Tecan Group Ltd. (Switzerland), Yokogawa Electric ... Read more
"Surge in projects regarding toxicity studies and drug discovery has led to an upsurge in demand for techniques related to high content screening in the pharmaceutical industry. Moreover, growing support from the government is expected to impact the global market growth of content screening positively. According to a recently published report by Trends market research (TMR), the global high content screening market is expected to witness a CAGR growth of XX% over the projected period, 2018 ... Read more
The overall high content screening market is expected to grow from USD 506.7 million in 2016 to USD 909.0 million by 2022, at a CAGR of 10.3% from 2017 to 2022.
The major factors driving the growth of the HTS market include initiatives undertaken by pharmaceutical and biotechnology companies, increasing R&D spending, technological advancements in HTS, and the availability of ... Read more
